UCHL1 and Miyoshi myopathy: In hematologic malignancy, UCHL1 was found to be overexpressed in mature B cell malignancy, including aggressive germinal center diffuse large B-cell lymphoma [17], and to be an aggressive biomarker in MM development [11].